BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 19903503)

  • 1. Liposomal modular complexes for simultaneous targeted delivery of bioactive gases and therapeutics.
    Klegerman ME; Wassler M; Huang SL; Zou Y; Kim H; Shelat HS; Holland CK; Geng YJ; McPherson DD
    J Control Release; 2010 Mar; 142(3):326-31. PubMed ID: 19903503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delivery of stem cells to porcine arterial wall with echogenic liposomes conjugated to antibodies against CD34 and intercellular adhesion molecule-1.
    Herbst SM; Klegerman ME; Kim H; Qi J; Shelat H; Wassler M; Moody MR; Yang CM; Ge X; Zou Y; Kopechek JA; Clubb FJ; Kraemer DC; Huang S; Holland CK; McPherson DD; Geng YJ
    Mol Pharm; 2010 Feb; 7(1):3-11. PubMed ID: 19719324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-Delivery of Therapeutics and Bioactive Gas Using a Novel Liposomal Platform for Enhanced Treatment of Acute Arterial Injury.
    Huang SL; Moody MR; Yin X; McPherson DD; Kim H
    Biomolecules; 2023 May; 13(5):. PubMed ID: 37238730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nitric oxide improves molecular imaging of inflammatory atheroma using targeted echogenic immunoliposomes.
    Kim H; Kee PH; Rim Y; Moody MR; Klegerman ME; Vela D; Huang SL; McPherson DD; Laing ST
    Atherosclerosis; 2013 Dec; 231(2):252-60. PubMed ID: 24267236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody-labeled liposomes for CT imaging of atherosclerotic plaques: in vitro investigation of an anti-ICAM antibody-labeled liposome containing iohexol for molecular imaging of atherosclerotic plaques via computed tomography.
    Danila D; Partha R; Elrod DB; Lackey M; Casscells SW; Conyers JL
    Tex Heart Inst J; 2009; 36(5):393-403. PubMed ID: 19876414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nitric oxide-loaded echogenic liposomes for nitric oxide delivery and inhibition of intimal hyperplasia.
    Huang SL; Kee PH; Kim H; Moody MR; Chrzanowski SM; Macdonald RC; McPherson DD
    J Am Coll Cardiol; 2009 Aug; 54(7):652-9. PubMed ID: 19660697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo volumetric intravascular ultrasound visualization of early/inflammatory arterial atheroma using targeted echogenic immunoliposomes.
    Kim H; Moody MR; Laing ST; Kee PH; Huang SL; Klegerman ME; McPherson DD
    Invest Radiol; 2010 Oct; 45(10):685-91. PubMed ID: 20733507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, acoustic stability, and pharmacologic activities of papaverine-loaded echogenic liposomes for ultrasound controlled drug delivery.
    Kee PH; Abruzzo TA; Smith DA; Kopechek JA; Wang B; Huang SL; MacDonald RC; Holland CK; McPherson DD
    J Liposome Res; 2008; 18(4):263-77. PubMed ID: 18720194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nitric oxide-loaded echogenic liposomes for treatment of vasospasm following subarachnoid hemorrhage.
    Kim H; Britton GL; Peng T; Holland CK; McPherson DD; Huang SL
    Int J Nanomedicine; 2014; 9():155-65. PubMed ID: 24379666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel liposomal nanomedicine for nitric oxide delivery and breast cancer treatment.
    Lee SY; Rim Y; McPherson DD; Huang SL; Kim H
    Biomed Mater Eng; 2014; 24(1):61-7. PubMed ID: 24211883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nitric Oxide-Enhanced Molecular Imaging of Atheroma using Vascular Cellular Adhesion Molecule 1-Targeted Echogenic Immunoliposomes.
    Kim H; Kee PH; Rim Y; Moody MR; Klegerman ME; Vela D; Huang SL; McPherson DD; Laing ST
    Ultrasound Med Biol; 2015 Jun; 41(6):1701-10. PubMed ID: 25819469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ultrasound-enhanced bevacizumab release from echogenic liposomes for inhibition of atheroma progression.
    Klegerman ME; Naji AK; Haworth KJ; Zou Y; Golunski E; Peng T; Britton GL; Huang SL; Holland CK; McPherson DD
    J Liposome Res; 2016; 26(1):47-56. PubMed ID: 25865025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo therapeutic gas delivery for neuroprotection with echogenic liposomes.
    Britton GL; Kim H; Kee PH; Aronowski J; Holland CK; McPherson DD; Huang SL
    Circulation; 2010 Oct; 122(16):1578-87. PubMed ID: 20921443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting of ICAM-1-directed immunoliposomes specifically to activated endothelial cells with low cellular uptake: use of an optimized procedure for the coupling of low concentrations of antibody to liposomes.
    Hua S; Chang HI; Davies NM; Cabot PJ
    J Liposome Res; 2011 Jun; 21(2):95-105. PubMed ID: 20429814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultrasound-facilitated thrombolysis using tissue-plasminogen activator-loaded echogenic liposomes.
    Tiukinhoy-Laing SD; Huang S; Klegerman M; Holland CK; McPherson DD
    Thromb Res; 2007; 119(6):777-84. PubMed ID: 16887172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of bubbles on measurement of drug release from echogenic liposomes.
    Kopechek JA; Haworth KJ; Radhakrishnan K; Huang SL; Klegerman ME; McPherson DD; Holland CK
    Ultrason Sonochem; 2013 Jul; 20(4):1121-30. PubMed ID: 23357288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stability of echogenic liposomes as a blood pool ultrasound contrast agent in a physiologic flow phantom.
    Radhakrishnan K; Haworth KJ; Huang SL; Klegerman ME; McPherson DD; Holland CK
    Ultrasound Med Biol; 2012 Nov; 38(11):1970-81. PubMed ID: 22929652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravascular ultrasound molecular imaging of atheroma components in vivo.
    Hamilton AJ; Huang SL; Warnick D; Rabbat M; Kane B; Nagaraj A; Klegerman M; McPherson DD
    J Am Coll Cardiol; 2004 Feb; 43(3):453-60. PubMed ID: 15013130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Efficacy of internalized RGD-modified echogenic liposomes in diagnosis and treatment in a mouse model of rheumatoid arthritis].
    Gan Z; Wu H; Wu HH; Zhou MJ; Yan F; Liu HM
    Nan Fang Yi Ke Da Xue Xue Bao; 2017 Oct; 37(10):1283-1289. PubMed ID: 29070455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Control of endothelial targeting and intracellular delivery of therapeutic enzymes by modulating the size and shape of ICAM-1-targeted carriers.
    Muro S; Garnacho C; Champion JA; Leferovich J; Gajewski C; Schuchman EH; Mitragotri S; Muzykantov VR
    Mol Ther; 2008 Aug; 16(8):1450-8. PubMed ID: 18560419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.